The HCWNY is a separate, non-profit New York State-licensed diagnostic and treatment center offering a variety of specialized diagnostic and health maintenance services for persons with bleeding and clotting disorders. The Hemophilia Center strives to improve the quality of life for people affected with these conditions through clinic services, advocacy, education and research initiatives.
The Magellan Group is working with executive and physician leadership in the development and implementation of a marketing campaign that will highlight services offered, as well as educate the public and physician practices in the diagnosis and treatment of bleeding and clotting disorders.